 Breast Cancer Drugs: World Market Prospects 2010-2025
You will receive a comprehensive analysis of the prospects for breast cancer drugs from 2010 to 2025, including predicted revenues, growth rates and other data for leading products
/ You will receive an overall sales forecast for that market area from 2010 to 2025, as well as that for main drug cla
Market: Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
2.224,00$ |
Developments in Pricing and Reimbursement in Leading Pharma Markets 2010-2020
You will receive a comprehensive analysis of pricing and reimbursement in leading pharmaceutical markets (US, Japan, Germany, France, UK, Italy and Spain)
/ You will find out how the pricing and reimbursement landscape will change from 2010 to 2020, with quantitative and qualitative analyses to ben
Market: Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
2.224,00$ |
In Vitro Diagnostics and Theranostics: World Market Analysis 2010-2025
You will receive a comprehensive analysis of the prospects for in-vitro diagnostics from 2010 to 2025, with quantitative and qualitative analyses
/ You will receive an overall revenue forecast for that market area from 2010 to 2025, as well as those for main subdivisions (by technology and applicat
Market: Diagnostics / Medical technology , Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
2.224,00$ |
Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025
You will receive a comprehensive analysis of the prospects for lyophilisation products and services, including predicted revenues and other data, by overall market and main subgroup/application
/ You will find out how the lyophilisation industry and market will change from 2010 to 2025, with sales
Market: Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
2.224,00$ |
Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025
You will assess the current market for monoclonal antibodies in cancer therapy
/ You will review the overall market from 2010 to 2025, including global sales forecasts
/ You will receive sales forecasts for the leading products in that market from 2010 to 2025, with discussions of market potential
Market: Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
2.224,00$ |
Able Laboratories, Inc. - Strategic Analysis Review
Able Laboratories, Inc. is engaged in the development and manufacturing of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms. The company is b
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Alliant Pharmaceuticals, Inc. - Strategic Analysis Review
Alliant Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on acquiring, developing and commercializing proprietary products for the pediatric and ped
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
AltaRex Medical Corp. - Strategic Analysis Review
This comprehensive SWOT profile of AltaRex Medical Corp. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by Gl
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
ANDRX Corporation - Strategic Analysis Review
Andrx Corporation is a pharmaceutical company engaged in developing and commercializing generic versions of primarily controlled-release pharmaceutical products as well as oral con
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
ARIUS Research Inc. - Strategic Analysis Review
ARIUS Research, Inc. is a biotechnology company discovering and developing the antibody therapeutics to treat cancer and other diseases
This comprehensive SWOT profile of ARIUS Re
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Astra Merck Inc. - Strategic Analysis Review
This comprehensive SWOT profile of Astra Merck Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalD
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Atrix Laboratories, Inc. - Strategic Analysis Review
Atrix Laboratories, Inc. a Fort Collins, Colorado based biopharmaceutical company focused on advanced drug delivery. The company currently developing a diverse portfolio of product
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
AXYS Pharmaceuticals, Inc - Strategic Analysis Review
This comprehensive SWOT profile of AXYS Pharmaceuticals, Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled b
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Beijing Centergate Technologies (Holding) Co., Ltd. - Strategic Analysis Review
This comprehensive SWOT profile of Beijing Centergate Technologies (Holding) Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The p
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Bone Care International, Inc. - Strategic Analysis Review
Bone Care International, Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of therapeutic products to treat the unmet medical needs of pa
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Bradley Pharmaceuticals, Inc. - Strategic Analysis Review
Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company. It acquires, develops, and markets prescription and over the counter products in therapeutic markets, including
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Calzada Limited - Strategic Analysis Review
This comprehensive SWOT profile of Calzada Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Cambridge Neuroscience - Strategic Analysis Review
This comprehensive SWOT profile of Cambridge Neuroscience provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by G
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
CeNeS Pharmaceuticals plc - Strategic Analysis Review
CeNeS Pharmaceuticals plc is a biopharmaceutical company. The company is engaged in the discovery and development of novel drug products for the treatment of disorders related to c
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
CIPAN - Cia Ind Prom de Ant SA - Strategic Analysis Review
This comprehensive SWOT profile of CIPAN - Cia Ind Prom de Ant SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compi
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
COLLTECH AUSTRALIA LIMITED - Strategic Analysis Review
This comprehensive SWOT profile of COLLTECH AUSTRALIA LIMITED provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
COR Therapeutics, Inc. - Strategic Analysis Review
This comprehensive SWOT profile of COR Therapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by G
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Corautus Genetics Inc. - Strategic Analysis Review
Corautus Genetics Inc. was acquired by VIA Pharmaceuticals, Inc. in a reverse merger transaction. It does not have significant operations. Previously, the company was focused on t
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Corgentech Inc. - Strategic Analysis Review
This comprehensive SWOT profile of Corgentech Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
Corixa Corporation - Strategic Analysis Review
Corixa Corporation is a biopharmaceutical company engaged in developing vaccine adjuvants and immunology based products that manage human diseases. The company primarily focuses on
Market: Pharmaceuticals / Medicines
|
2010 |
125,00$ |
